Media

The Biotechnology Industry Organization (BIO) today announced that it will showcase a series of unique sessions at this year’s Livestock Biotech Summit...
Sessions to focus on the FDA Breakthrough Therapy Designation Process, IPO Market, and BioCentury’s Back to School issue

Press Releases

Mar 16 2002
Washington, D.C. (March 16, 2002)- The deadline for on-line registration for those seeking media credentials for BIO 2002 in Toronto is Friday, May 24, 2002....
Mar 13 2002
Washington, D.C. (March 13, 2002)-The Biotechnology Industry Organization (BIO) announced today that discussions with the Food and Drug Administration and the...
Mar 12 2002
WASHINGTON, D.C. (March 12, 2002) - The Interoperable Informatics Infrastructure Consortium (I3C) which was incorporated on Feb. 13, 2002, held its first...
Mar 7 2002
WASHINGTON, D.C. (March 7, 2002) – The advance program for the BIO 2002 International Biotechnology Convention & Exhibition is available online at...
Mar 5 2002
March 5, 2002 (Washington, D.C.)-In conjunction with today’s hearing by the Senate Health, Education, Labor and Pensions Committee on “The Dangers...
Mar 5 2002
WASHINGTON, D.C. (March 5, 2002) - Mary Pendergast, executive vice president for government affairs at Elan Pharmaceuticals, will testify tomorrow on behalf of...
Mar 4 2002
(WASHINGTON, DC) - March 4, 2002 - After a four-month delay, the Centers for Medicare and Medicaid Services (CMS) issued a corrected regulation on pass-through...
Mar 4 2002
PDF copy of Special Section (654 KB)
Feb 28 2002
Washington, D.C. (February 28, 2002)-The board of directors of the Biotechnology Industry Organization (BIO) voted unanimously to add Susan Desmond-Hellmann, M...